Professor John P. Greenwood
MBChB | PhD | FRCP(UK) | FACC | FESC | FBCS(Hon) | FSCMR, FICS(Hon)
Honorary Professor of Cardiology
University of Melbourne
Monash University
University of Leeds, UK
Honorary Consultant Cardiologist
The Alfred Hospital, Melbourne
Leeds Teaching Hospitals NHS Trust, UK
Director and CEO
+61 3 8532 1550 john.greenwood@baker.edu.auProfessor John Greenwood is the Director of the Baker Heart and Diabetes Institute, Melbourne, Australia and Adjunct/Visiting Professor at Melbourne University, Monash University, and also the University of Leeds, UK. As a consultant cardiologist for 20 years, he has specialised in coronary intervention and cardiovascular magnetic resonance (CMR) imaging.
Professor Greenwood underwent his clinical and academic training in Leeds, UK, and in addition underwent specialist training in coronary intervention in Toulouse, France and Cardiovascular Magnetic Resonance (CMR) imaging at the Royal Brompton Hospital, London.
His main focus of research has been the diagnosis and treatment of stable and unstable coronary artery disease. In terms of diagnostics, this particularly involved the use of CMR in terms of pulse sequence development and validation through large-scale clinical trials. In terms of therapeutics, he has collaborated on a number of major multi-centre clinical trials designed to improve outcomes in patients undergoing primary PCI for acute ST elevation myocardial infarction or stable complex coronary artery disease. In particular, early phase clinical trials of drugs and devices to reduce infarct size in the setting of acute myocardial infarction.
He is the current President of the British Cardiovascular Society (BCS; 2021–2024) and a member of Council of The Royal College of Physicians, London. He was elected to the Board of BSCMR (British Society of Cardiovascular MR) in 2008, and became BSCMR President (2018–2020). He is past-Chair of the SCMR clinical trials committee (2015–2017) and a member of the SCMR scientific programme committee (2016–2019). He was the SCMR representative on the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain.
He was a winner of the SCMR Gold Medal in 2023 and Associate Editor of JCMR (2017–2023). He is a member of the ESC Cardio-policy group (2022–2024), ESC Advocacy Committee (2021–current) and a member of the Assembly of International Governors of the ACC.
He has supervised/co-supervised to completion ~30 MD/PhD students and has ~400 peer-reviewed publications, including many in NEJM, Lancet, JAMA, Circulation, JACC and EHJ.